Page last updated: 2024-10-24

autophagosome maturation

Definition

Target type: biologicalprocess

Removal of PI3P and Atg8/LC3 after the closure of the phagophore and before the fusion with the endosome/lysosome (e.g. mammals and insects) or vacuole (yeast), and that very likely destabilizes other Atg proteins and thus enables their efficient dissociation and recycling. [GOC:autophagy, GOC:lf, PMID:28077293]

Autophagosome maturation is a complex process that involves the formation of a double-membrane vesicle called an autophagosome, which engulfs cellular components destined for degradation. This process is tightly regulated and involves multiple signaling pathways and protein interactions.

The initial step in autophagosome maturation is the formation of an isolation membrane, also known as a phagophore. This membrane originates from the endoplasmic reticulum (ER) and expands to enclose the cargo. The formation of the phagophore is mediated by a complex interplay of autophagy-related proteins (ATGs).

Once the phagophore has enclosed the cargo, it undergoes a series of elongation and closure steps to form a complete autophagosome. The elongation process involves the recruitment of additional membrane components and the assembly of specialized protein complexes. Key ATGs involved in this process include ATG5, ATG7, ATG12, and ATG16L1, which form a complex that facilitates the recruitment of the lipidated form of LC3 (LC3-II) to the phagophore membrane.

The closure of the autophagosome is a critical step that ensures the integrity of the double-membrane structure. This step involves the fusion of the two ends of the elongating phagophore, which is mediated by proteins such as ATG14L and ATG18.

Once the autophagosome is fully formed, it moves towards the lysosome, the cellular degradation center. The fusion of the autophagosome with the lysosome is mediated by the SNARE protein complex and involves the recruitment of lysosomal proteins like LAMP1 and LAMP2. This fusion event results in the formation of an autolysosome, where the engulfed cargo is degraded by lysosomal enzymes.

The degradation of the cargo within the autolysosome is a crucial aspect of autophagy. This process is facilitated by the acidic environment and the action of hydrolytic enzymes present in the lysosome. The breakdown products, such as amino acids, fatty acids, and sugars, can be recycled back into the cell to provide energy and building blocks.

Autophagosome maturation is a dynamic and tightly regulated process that is essential for cellular homeostasis and survival. Dysregulation of this process can lead to various diseases, including cancer, neurodegenerative disorders, and infectious diseases.'
"

Proteins (4)

ProteinDefinitionTaxonomy
Microtubule-associated proteins 1A/1B light chain 3AA microtubule-associated proteins 1A/1B light chain 3A that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H492]Homo sapiens (human)
Microtubule-associated proteins 1A/1B light chain 3BA microtubule-associated proteins 1A/1B light chain 3B that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9GZQ8]Homo sapiens (human)
Phosphatidylinositol 3-kinase catalytic subunit type 3A phosphatidylinositol 3-kinase catalytic subunit type 3 that is encoded in the genome of human. [PRO:DNx]Homo sapiens (human)
Transitional endoplasmic reticulum ATPaseA transitional endoplasmic reticulum ATPase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P55072]Homo sapiens (human)

Compounds (31)

CompoundDefinitionClassesRoles
clotrimazoleconazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes
antiinfective agent;
environmental contaminant;
xenobiotic
Methylenedioxycinnamic acidhydroxycinnamic acid
3,4-methylenedioxy-beta-nitrostyrene3,4-methylenedioxy-beta-nitrostyrene: tyrosine kinase inhibitor that prevents platelet glycoprotein IIb/IIIa activation; structure in first source
4-(4-(4-chloro-phenyl)thiazol-2-ylamino)phenolsubstituted aniline
ML162ML162 : A monochlorobenzene that is benzene substituted by (chloroacetyl){2-oxo-2-[(2-phenylethyl)amino]-1-(thiophen-2-yl)ethyl}amino, chloro and methoxy groups at positions 1, 3 and 4, respectively. It is a covalent inhibitor of glutathione peroxidase 4 (GPX4) that induces ferroptosis in cells.monochlorobenzenes;
monomethoxybenzene;
organochlorine compound;
secondary carboxamide;
tertiary carboxamide;
thiophenes
EC 1.11.1.9 (glutathione peroxidase) inhibitor;
ferroptosis inducer
PI3-Kinase alpha Inhibitor 2organic heterobicyclic compound;
organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
idelalisibidelalisib : A member of the class of quinazolines that is 5-fluoro-3-phenylquinazolin-4-one in which the hydrogen at position 2 is replaced by a (1S)-1-(3H-purin-6-ylamino)propyl group. used for for the treatment of refractory indolent non-Hodgkin's lymphoma and relapsed chronic lymphocytic leukemia.

idelalisib: an antineoplastic agent and p110delta inhibitor; structure in first source
aromatic amine;
organofluorine compound;
purines;
quinazolines;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
zstk474ZSTK-474 : A triamino-1,3,5-triazine that is 1,3,5-triazine in which two of the hydrogens have been replaced by morpholin-4-yl groups while the third hydrogen has been replaced by a 2-(difluoromethyl)benzimidazol-1-yl group. It is an inhibitor of phosphatidylinositol 3-kinase.benzimidazoles;
morpholines;
organofluorine compound;
triamino-1,3,5-triazine
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
dactolisibdactolisib : An imidazoquinoline that is 3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinoline substituted at position 1 by a 4-(1-cyanoisopropyl)phenyl group and at position 8 by a quinolin-3-yl group. A dual PI3K/mTOR inhibitor used in cancer treatment.

dactolisib: antineoplastic agent that inhibits both phosphatidylinositol 3-kinase and mTOR
imidazoquinoline;
nitrile;
quinolines;
ring assembly;
ureas
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
ku 60019
buparlisibNVP-BKM120: a pan class I PI3 kinase inhibitor with antineoplastic activity; structure in first sourceaminopyridine;
aminopyrimidine;
morpholines;
organofluorine compound
antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
gdc 0941pictrelisib : A sulfonamide composed of indazole, morpholine, and methylsulfonyl-substituted piperazine rings bound to a thienopyrimidine ring.indazoles;
morpholines;
piperazines;
sulfonamide;
thienopyrimidine
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
gdc 0980
azd2014vistusertib: potent and selective dual mTORC1 and mTORC2 inhibitor; structure in first source
pki 587gedatolisib: inhibits both phosphatidylinositol 3-kinase and mTOR; structure in first source
5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-aminesapanisertib: an mTOR inhibitorbenzoxazole
ch 5132799CH 5132799: structure in first source
ML240ML240 : A member of the class of quinazolines that is quinazoline which is substituted at positions 2, 5 and 8 by 2-amino-1H-benzimidazol-1-yl, benzylnitrilo and methoxy groups, respectively. It is a ATP-competetive inhibitor of AAA ATPase p97, also known as valosin-containing protein (VCP).aromatic amine;
aromatic ether;
benzimidazoles;
primary amino compound;
quinazolines;
secondary amino compound
antineoplastic agent
torin 1torin 1 : A member of the class of pyridoquinolines that is 9-(quinolin-3-yl)benzo[h][1,6]naphthyridin-2-one bearing an additional 4-(4-propionylpiperazin-1-yl)-3-(trifluoromethyl)phenyl substituent at position 1. It is a potent inhibitor of mTOR and exhibits anti-cancer properties.N-acylpiperazine;
N-arylpiperazine;
organofluorine compound;
pyridoquinoline;
quinolines
antineoplastic agent;
mTOR inhibitor
gdc-0032
spautin-1
torin 2torin 2 : A member of the class of pyridoquinolines that is benzo[h][1,6]naphthyridin-2-one carrying additional 3-(trifluoromethyl)phenyl and 6-aminopyridin-3-yl substituents at positions 1 and 9 respectively. It is a potent inhibitor of mTOR and exhibits anti-cancer properties.aminopyridine;
organofluorine compound;
primary amino compound;
pyridoquinoline
antineoplastic agent;
mTOR inhibitor
cudc-907
novobiocinnovobiocin : A coumarin-derived antibiotic obtained from Streptomyces niveus.

Novobiocin: An antibiotic compound derived from Streptomyces niveus. It has a chemical structure similar to coumarin. Novobiocin binds to DNA gyrase, and blocks adenosine triphosphatase (ATPase) activity. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p189)
carbamate ester;
ether;
hexoside;
hydroxycoumarin;
monocarboxylic acid amide;
monosaccharide derivative;
phenols
antibacterial agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Escherichia coli metabolite;
hepatoprotective agent
sar245408
byl719proline derivative
amg 511AMG 511: structure in first source
cc-223
sar405SAR405: a Vps34 inhibitor with antineoplastic activity; structure in first source
dihydronovobiocindihydronovobiocin: high affinity for DNA gyrase B; structure given
ganciclovir2-aminopurines;
oxopurine
antiinfective agent;
antiviral drug